Summit Therapeutics Inc. Common Stock (SMMT) Price and Market Data
Explore real-time Summit Therapeutics Inc. Common Stock (SMMT) price, market cap, trading volume, and price changes. View the live price chart and key reference data.
Summit Therapeutics Inc. Common Stock price chart
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridioides difficile infection) product candidate is ridinilazole, an orally administered small-molecule antibiotic. The company operates across two geographic segments: the United States and the United Kingdom.
Reference
- Exchange
- XNAS
- Sector
- PHARMACEUTICAL PREPARATIONS
- Employees
- 265
- Listed
- 3/5/2015
- Market cap
- $13.179B
- Shares outstanding
- 776,079,959
- Currency
- usd
- Website
- https://www.smmttx.com